Is Antiretroviral Therapy Causing Long-Term Liver Damage? A Comparative Analysis of HIV-Mono-Infected and HIV/Hepatitis C Co-Infected Cohorts

Erica E. M. Moodie, Nitika Pant Pai, Marina B. Klein · 2009

Read Is Antiretroviral Therapy Causing Long-Term Liver Damage? A Comparative Analysis of HIV-Mono-Infected and HIV/Hepatitis C Co-Infected Cohorts by Erica E. M. Moodie, Nitika Pant Pai, Marina B. Klein (2009) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/plos-pone-0004517.txt.

Description

Powerful HIV drugs may carry a long-term cost for the liver, a question examined by Erica Moodie, Nitika Pant Pai, and Marina Klein in PLOS ONE in 2009. Highly active antiretroviral therapy, called HAART, transformed HIV care. Yet deaths from liver disease rose in the years after HAART arrived, and its effect on liver scarring in people also infected with hepatitis C was not well understood.

The team compared two groups: people infected with HIV alone, and people infected with both HIV and hepatitis C. Some earlier snapshot studies had hinted HAART might protect the liver, which made the question harder. A careful comparison of the two groups can separate drug effects from virus effects. The answer guides how doctors watch livers during lifelong HIV treatment.

Catalog record

CREATORErica E. M. Moodie, Nitika Pant Pai, Marina B. Klein
YEAR2009
COLLECTIONPAPERS
FORMATTXT
FILE SIZE33 KB
LICENSECreative Commons Attribution License
RIGHTSCC BY
SOURCEPLOS ONE

Source: https://journals.plos.org/plosone/article?id=10.1371/journal.pone.0004517

Browse the full library · About the Tower of Babel